obesity drug news today glp-1 october 21 2025 Alarming rise in weight loss overdoses Pharma Giants Bet on Next-Generation
Description
NF-kappaB regulation in the immune system
Ethical approval was not required as the study was conducted using de-identified publicly available data
Bosters advice for those with MS
Eric Xu Qilu Regor Therapeutics Inc., 1206 Zhangjiang Road, Building C, Pu Dong New District, Shanghai, 201210, China Wei Huang, Wei Guo, Xianqiang Sun, Wenge Zhong & Daopeng Yuan Regor Pharmaceuticals Inc., 50 Soldiers Field Pl, Boston, MA, 02135, USA Feng Liu Authors Honglei Ma Wei Huang Xiaoxi Wang Lihua Zhao Yi Jiang Feng Liu Wei Guo Xianqiang Sun Wenge Zhong Daopeng Yuan H
Pharmacokinetics and discontinuation timing Analysis of pharmacokinetic data highlighted significant variability in half-lives across GLP-1 RAs
liraglutide protects isolated mouse neonatal cardiomyocytes and human coronary smooth muscle cells from palmitate-induced lipotoxicity
